Why NeoGenomics, Inc.’s (NEO) Stock Is Down 5.20%
As of Friday, November 13, NeoGenomics, Inc.’s NEO share price has dipped by 5.20%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Rosalio Madrigal
Michael Rose
Omar Beirat
| Share Statistics | NEO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,072.8 | $1,942.6 | 55% |
|
| Shares Out (Mil) | 128.6 | 80.2 | 67% |
|
| Institutional Ownership | 98.1% | 86.2% | 77% |
|
| Float (Mil) | 117.9 | 58.7 | 64% |
|
| Beta | 1.78 | 0.67 | 88% |
|
| Avg Daily Volume (000s) | 1,554 | 706 | 75% |
|
| Price Change (52-week) |
60.2% | 80.9% | 90% |
|
| Growth | NEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.4% | 10.3% | 60% |
|
| Net Income (5yr) | (94.3%) | (0.7%) | 2% |
|
| EPS (5yr) | (89.1%) | 2.1% | 1 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (33.8%) | (17.4%) | 16% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 10 | 11 | |
| Current EPS | $0.065 | $0.204 | $0.315 | |
| Month Ago EPS | $0.070 | $0.187 | $0.343 | |
| # Rev Up | 2 | 1 | 0 | |
| # Rev Down | 1 | 0 | 3 | |
| Three Months Ago EPS | $0.069 | $0.183 | $0.338 | |
| Year/Year Chg | (208.3%) | (124.2%) | (149.8%) | |
| Financials | NEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $788 | $1,505 | 46% |
|
| Net Income (TTM) (Mil) | ($32) | $30 | 20% |
|
| EPS (TTM) | ($0.250) | $0.300 | 31% |
|
| Operating Cash Flow (TTM) (Mil) | $4 | $170 | 35% |
|
| Net Cash Flow (TTM) (Mil) | ($25) | $6 | 27% |
|
| Long-Term Debt (Q1) (Mil) | $443 | $421 | 57% |
|
| Enterprise Value (Q1) (Mil) | $2,559 | $2,396 | 52% |
|
| Valuation | NEO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.58 | 2.87 | 64% |
|
| P/E | na | 27.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | NEO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 44.8% | 27.9% | 56% |
|
| Net Margin | (4.1%) | 1.4% | 25% |
|
| ROA | (2.3%) | 2.4% | 33% |
|
| ROE | (3.9%) | 7.4% | 31% |
|
| Liabilities to Assets | 41.9% | 61.9% | 32% |
|
| F-Score | 5 | 5 | 50% |
|
NeoGenomics, Inc. did not pass any screens on 11/13/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors